Statin and Atheroma Vulnerability Evaluation

NCT00997880 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

312

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Rosuvastatin calcium 40mg
DRUG: Rosuvastatin calcium10mg

Sponsor

Seung-Jung Park

Collaborators

[object Object]